CPC technology class · C07
C07B - General Methods OF Organic Chemistry
General methods of organic chemistry; apparatus therefor. 8,058 US utility patents granted 2015–2025, with the leading assignees and year-by-year filing trajectory.
- 8,058
- US patents granted
- C07
- Parent CPC class
- 20
- Active assignees
- +36%
- 5-yr velocity
The verdict
General Methods OF Organic Chemistry ranks #191 of 670 CPC technology areas - 8,058 US patents granted since 2015, with filing up 36% over five years.
- #191
- of 670 CPC technology areas
- 8,058
- US patents granted, 2015–2025
- Incyte
- leading assignee (89)
- +36%
- filing velocity, last 5 yrs
CPC subclass C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR - covers 8,058 US utility patents granted between 2015 and 2025 according to USPTO PatentsView records, within the broader CPC class C07 (ORGANIC CHEMISTRY). See our CPC classification guide for how the system works.
The competitive landscape in C07B is shaped by 20 distinct companies actively filing in this space. Incyte Corporation leads with 89 patents, followed by Novartis Ag at 82 grants and Bristol-myers Squibb Company at 67.
Filing activity in C07B is up 36% over the past five years versus 2015-2019, a sharp acceleration suggesting an emerging or fast-moving technology area. All counts come directly from USPTO PatentsView and reflect US granted utility patents only.
Is C07B innovation accelerating?
US utility-patent grants per year in C07B, 2015–2025 - recent five years are up 36% versus 2015–2019.
Who leads C07B?
The 12 most active assignees in GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR - wider bars mean more grants
- Incyte
Incyte Corporation
89 patents
- Novartis
Novartis AG
82 patents
- Bristol-myers Squibb
Bristol-Myers Squibb Company
67 patents
- Abb Vie
Abb Vie Inc.
64 patents
- Pfizer
PFIZER INC.
63 patents
- Concert Pharmaceutica…
Concert Pharmaceuticals, Inc.
57 patents
- Gilead Sciences
Gilead Sciences, Inc.
56 patents
- Vertex Pharmaceutical…
Vertex Pharmaceuticals Incorporated
55 patents
- Merck Sharp & Dohme
Merck Sharp & Dohme LLC
54 patents
- Janssen Pharmaceutica…
Janssen Pharmaceuticals, Inc.
54 patents
- Celgene
CELGENE CORPORATION
53 patents
- Theravance Biopharma…
Theravance Biopharma R&D IP, LLC
51 patents
What this shows Incyte is the most active filer in C07B, holding 89 of the 8,058 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.
View data table
| Rank | Company | Patents in C07B |
|---|---|---|
| #1 | Incyte Corporation | 89 |
| #2 | Novartis Ag | 82 |
| #3 | Bristol-myers Squibb Company | 67 |
| #4 | Abb Vie Inc. | 64 |
| #5 | Pfizer Inc. | 63 |
| #6 | Concert Pharmaceuticals, Inc. | 57 |
| #7 | Gilead Sciences, Inc. | 56 |
| #8 | Vertex Pharmaceuticals Incorporated | 55 |
| #9 | Merck Sharp & Dohme Llc | 54 |
| #10 | Janssen Pharmaceuticals, Inc. | 54 |
| #11 | Celgene Corporation | 53 |
| #12 | Theravance Biopharma R&D IP, Llc | 51 |
| #13 | KING Faisal University | 47 |
| #14 | Daiichi Sankyo Company, Limited | 47 |
| #15 | Mitsubishi Gas Chemical Company, Inc. | 42 |
| #16 | GE Healthcare Limited | 42 |
| #17 | Hoffmann-la Roche Inc. | 37 |
| #18 | Amgen Inc. | 34 |
| #19 | Council OF Scientific AND Industrial Research | 34 |
| #20 | Takeda Pharmaceutical Company Limited | 34 |
About This Class
CPC subclass C07B belongs to class C07.
8,058 patents were granted in this class between 2015 and 2025.
20 companies actively patent in this space.
Classification System
Cooperative Patent Classification (CPC) is a hierarchical patent classification system used by the USPTO and EPO.
Footprint here vs. claim strategy
Each dot is a leading C07B assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.
Top 14 C07B assignees by class footprint. Bubble size = patents in C07B. Source: USPTO PatentsView (claim depth is company-wide across all classes).
Frequently Asked Questions
What is CPC class C07B?
How many patents have been filed in C07B?
Which company holds the most patents in C07B?
How is patent data for C07B collected?
What is the difference between CPC class and subclass?
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.